Antibody blockade of Thy-1 (CD90) impairsmouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody

被引:15
|
作者
Haeryfar, SM
Conrad, DM
Musgrave, BL
Hoskin, DW
机构
[1] Dalhousie Univ, Fac Med, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada
[2] Dalhousie Univ, Fac Med, Dept Pathol, Halifax, NS B3H 1X5, Canada
来源
IMMUNOLOGY AND CELL BIOLOGY | 2005年 / 83卷 / 04期
关键词
costimulation; cytokine; cytotoxicity; signal transduction; T lymphocyte; Thy-1;
D O I
10.1111/j.1440-1711.2005.01342.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Thy-1 (CD90)expressed by mouse T cells is known to have signal transducing properties,but the ability of Thy-1 to enhance cytotoxic T lymphocyte (CTL)development is not well understood. Here we show that stimulationof mouse T cells with monoclonal antibodies (mAb) to CD3, CD28 andThy-1 (clone G7), which were coimmobilized on polystyrene microbeads,resulted in a greater proliferative response than stimulation withonly anti-CD3 and anti-CD28 mAb, indicating that Thy-1 cross-linkingenhanced T cell receptor/CD28-driven T cell activation.Consistent with this finding, Thy-1 blockade with a soluble nonactivatinganti-Thy-1 mAb (clone 30-H12) inhibited anti-CD3-induced proliferationof CD4(+) and CD8(+) T cells,and the induction of cytotoxic effector cells in a dose-dependentfashion. Interleukin-2 synthesis and CD25 expression were also impairedby Thy-1 blockade. The inhibitory effect involved a defect at orbefore the level of protein kinase C activation because the additionof phorbol ester ablated the anti-Thy-1-mediated inhibition of anti-CD3-inducedT cell activation. The CTL that were induced in the presence ofblocking anti-Thy-1 mAb adhered to target cells but showed reducedexpression of granzyme B and perforin. In contrast, Fas ligand expressionand function was not affected by Thy-1 blockade. We conclude thatThy-1 signalling promotes the in vitro generation of CTLthat kill in a granule-dependent fashion.
引用
收藏
页码:352 / 363
页数:12
相关论文
共 50 条
  • [31] Monoclonal Antibody 10A5 (Anti Rat Thy-1)
    Kuroiwa, Kenji
    HYBRIDOMA, 2012, 31 (04): : 297 - 297
  • [32] ANTI-CD3 MONOCLONAL-ANTIBODY INDUCES TOLERANCE TO ALLOANTIGENS IN RATS
    NICOLLS, MR
    AVERSA, GG
    PEARCE, NW
    SPINELLI, A
    BERGER, MF
    GURLEY, KE
    HALL, BM
    CLINICAL RESEARCH, 1991, 39 (02): : A380 - A380
  • [33] Anti-CD3 monoclonal antibody as a possible therapeutic alternative in HAM/TSP
    Johan Van Weyenbergh
    Daniele Decanine
    Saul Velloso Schnitman
    Ana Maria Moro
    Jorge Kalil
    Ramon A Kruschewsky
    Bernardo Galvão-Castro
    Retrovirology, 11 (Suppl 1)
  • [34] Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody
    Ishikawa, Hiroki
    Ochi, Hirofumi
    Chen, Mei-Ling
    Frenkel, Dan
    Maron, Ruth
    Weiner, Howard L.
    DIABETES, 2007, 56 (08) : 2103 - 2109
  • [35] PREVENTION OF AUTOIMMUNE DIABETES WITH NONACTIVATING ANTI-CD3 MONOCLONAL-ANTIBODY
    HEROLD, KC
    BLUESTONE, JA
    MONTAG, AG
    PARIHAR, A
    WIEGNER, A
    GRESS, RE
    HIRSCH, R
    DIABETES, 1992, 41 (03) : 385 - 391
  • [36] INDUCTION OF NK ACTIVITY IN LARGE ANTIGRANULOCYTES LYMPHOCYTE LEUKEMIA - ACTIVATION WITH ANTI-CD3 MONOCLONAL-ANTIBODY AND INTERLEUKIN-2
    LOUGHRAN, TP
    DRAVES, KE
    STARKEBAUM, G
    KIDD, P
    CLARK, EA
    BLOOD, 1987, 69 (01) : 72 - 78
  • [37] Melanoma Cells Use Thy-1 (CD90) on Endothelial Cells for Metastasis Formation
    Schubert, Kathleen
    Gutknecht, Danny
    Koeberle, Margarethe
    Anderegg, Ulf
    Saalbach, Anja
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (01): : 266 - 276
  • [38] Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
    Herold, KC
    Hagopian, W
    Auger, JA
    Poumian-Ruiz, E
    Taylor, L
    Donaldson, D
    Gitelman, SE
    Harlan, DM
    Xu, DL
    Zivin, RA
    Bluestone, JA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22): : 1692 - 1698
  • [39] Use of anti-CD3 monoclonal antibody to induce immune regulation in type 1 diabetes
    Bisikirska, BC
    Herold, KC
    IMMUNOLOGY OF DIABETES III, 2004, 1037 : 1 - 9
  • [40] Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response
    Furlong, Suzanne
    Coombs, Melanie R. Power
    Ghassemi-Rad, Javad
    Hoskin, David W.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2018, 6